The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.
Continuous combination oral contraceptive pills to eliminate withdrawal bleeding: a randomized trial
Abstract
OBJECTIVE: To compare bleeding profiles of a traditional 28-day oral contraceptive pill cycle with continuous administration. METHODS: After a 28-day run-in cycle, women were randomized to either 28-day cycles (21 active pills and a pill-free week) or continuous use of the same 20 microg ethinyl estradiol/100 microg levonorgestrel formulation for 12 study cycles (336 days). The number of bleeding and spotting days were measured by daily diary. A subset underwent cycle 1 (n = 16), and nine (n = 14) pelvic ultrasound and endometrial histology sampling. Blood pressure, weight, hemoglobin, and adverse events were measured at revisit. The sample size with 80% power to detect a 67% reduction in bleeding days required 27 subjects in each arm. RESULTS: Of the 79 subjects randomized, 28 (70%) of the 28-day cycle and 32 (82%) of the continuous-use subjects completed the entire study (P =.6). With continuous use, 49%, 68%, and 88% of women reported no bleeding during cycles 2, 6, and 12, respectively. Amenorrhea or infrequent bleeding was present in 68% of continuous users during cycles 1-3 and increased to 88% during cycles 10-12. Spotting during cycle days 1-21 increased initially with continuous use but reduced over time, and by 9 months was less than the spotting reported by cyclic users. Adverse events, blood pressure, weight, and hemoglobin findings were similar between groups. CONCLUSION: Extension of the 28-day oral contraceptive cycle to continuous use with a low-estrogen dose combination oral birth control pill resulted in significantly fewer bleeding days.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Vercellini, P., De Giorgi, O., Mosconi, P., Stellato, G., Vicentini, S., & Crosignani, P. G. (2002) · Fertility and Sterility · doi:10.1016/s0015-0282(01)02951-x · Cited by 180 · cited 3×
“5 mg) or a continuous OC (20- g ethinyl estradiol/150- g desogestrel) for 6 months to prevent disease reoccurrence.(18) At 6 months, the mean endometrial double layer thickness was 3.”
BackgroundInfluential
Cited by
LEE, C. A., CHI, C., PAVORD, S. R., BOLTON‐MAGGS, P. H. B., POLLARD, D., HINCHCLIFFE‐WOOD, A., & KADIR, R. A. (2006) · Haemophilia · doi:10.1111/j.1365-2516.2006.01314.x · Cited by 280
Continuous or extended cycle vs. cyclic use of combined hormonal contraceptives for contraception
Edelman, A., Micks, E., Motu’apuaka, M. L., Benson, L. S., & Stewart, F. (2014) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd004695.pub3 · Cited by 271
Evaluation of extended and continuous use oral contraceptives
Johnson, J. (2008) · Therapeutics and Clinical Risk Management · doi:10.2147/tcrm.s2143 · Cited by 55
“After trials to confi rm effi cacy and safety, extended cycle oral contraceptives became available in 2003 (Miller and Hughes 2003; Anderson and Hait 2003).”
Bourdel, N., Matsusakï, S., Roman, H., Lenglet, Y., Botchorischvili, R., Mage, G., & Canis, M. (2006) · Gynécologie Obstétrique & Fertilité · doi:10.1016/j.gyobfe.2006.07.008 · Cited by 14
Metadata
- Authors
- Miller, L.
- Venue
- Obstetrics & Gynecology
- Published
- 2003-04
- Volume
- 101
- Issue
- 4
- Pages
- 653-661
- ISSN
- 0029-7844 (ISSN-L)
- OpenAlex
- W2113520440
- Cited by
- 180
- References
- 1
- FWCI
- 15.17
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Continuous combination oral contraceptive pills to eliminate withdrawal bleeding: a randomized trial. https://app.cochat.ai/papers/10.1016/s0029-7844(03)00014-0
- The paper
- Miller, L. (2003). Continuous combination oral contraceptive pills to eliminate withdrawal bleeding: a randomized trial. Obstetrics & Gynecology. https://doi.org/10.1016/s0029-7844(03)00014-0
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.